EPO Enlarged Board of Appeal issues G 2/21 decision

Board provides guidance on evidence submitted after patent filing date | Eagerly awaited decision confirms what’s needed to prove a certain effect.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

Siemens ordered to recall mammography device across European countries

11 June 2026 The UPC has dealt Siemens a loss against a rival US medtech company, upholding a key breast imaging patent and addressing a range of issues from infringement and validity to recall orders and software-based workarounds.

Europe

Exclusive: ‘When a UPC judge wears their robe, they have no gender’

9 June 2026 In the second of a series of interviews with women judges at the Unified Patent Court, Carine Gillet shares her views with Sarah Speight on encouraging more women into technical judicial careers, how equipped the court is to handle life sciences disputes, and more.

Europe

UPC dispute resolution forum opens with ceremony in Slovenia

2 June 2026 The court has officially opened its mediation and arbitration forum, with technology, life sciences and manufacturing companies expected to be among its earliest users—particularly in FRAND and licensing cases.

More features

Siemens ordered to recall mammography device across European countries

MoFo bags IP trial duo with 50 years’ combined experience

US biotech fires trade secrets suit at Chinese pharma group

Hikma v Amarin: Six takeaways from the pivotal ruling

Exclusive: ‘When a UPC judge wears their robe, they have no gender’

Clarivate’s new IP president to ‘usher in next phase of growth’

Fed Circ rejects Nexus’ appeal in generics row with biopharma firm

Ex-Kirkland patent litigator jumps to rival firm

EPO Enlarged Board of Appeal issues G 2/21 decision

More on this story

Editor's picks

Editor's picks

More features